肠道微生物组与患有囊性纤维化症的婴儿的生长之间的关联
A R Deschamp1, Y Chen2, W F Wang2
1Indiana University School of Medicine, Riley Children's Hospital, 340 10th Street, Indianapolis, IN 46202, United States of America.
概括
患有囊性纤维化 (CF) 的婴儿在美国和澳大利亚之间表现出明显的肠道微生物群差异. 在CF婴儿中,营养不良和抗生素使用与减少短链脂肪酸的产生有关.
科学领域:
- 微生物学 微生物学
- 儿科 儿科 儿科
- 胃肠病学 胃肠病学
背景情况:
- 囊性纤维化 (CF) 改变了胃肠道,导致营养不良和肠道微生物组的变化.
- 这些微生物组变化与CF患者的生长,炎症和呼吸系统问题有关.
- 了解这些肠道微生物组的变化对于未来CF的营养管理策略至关重要.
研究的目的:
- 在不同地理位置 (美国与澳大利亚) 调查和比较患有囊性纤维化 (CF) 的婴儿的肠道微生物组组成和多样性.
- 确定肠道微生物丰富度与年龄,抗生素预防,营养不良和母乳养等因素之间的关联.
- 探索微生物组变化的功能影响,特别是关于短链脂肪酸 (SCFA) 生产.
主要方法:
- 在美国和澳大利亚的四个地点,从12个月内患有CF的婴儿收集了纵向便样本.
- 使用16S rRNA基因测序来分析肠道微生物组合.
- 用通用线性混合模型来评估微生物丰富度与临床因素之间的关联,包括营养不良和抗生素使用.
主要成果:
- 与美国 (US-CF) 相比,澳大利亚的CF婴儿 (AUS-CF) 表现出较低的肠道微生物α多样性.
- 在AUS-CF的婴儿中,蛋白质细菌的相对丰度较高,与抗生素预防有关.
- CF 婴儿的营养不良与乳球菌枯竭有关,并预测SCFA 生产代谢通路的减少.
结论:
- 美国和澳大利亚的CF婴儿之间存在肠道微生物组合和多样性的显著差异.
- 发现肠道微生物多样性与该队列的线性生长没有直接相关.
- 营养不良,抗生素预防和CF婴儿中SCFA发酵减少之间的相互作用需要进一步研究其对肠道健康的影响.
相关概念视频
Anatomy of the Intestines
72.4K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.4K
Cystic Fibrosis: Pathogenesis
280
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
280
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194


